Cormedix Inc (CRMD)
5.22
+0.14
(+2.76%)
USD |
NASDAQ |
May 22, 16:00
5.22
0.00 (0.00%)
After-Hours: 20:00
Cormedix Cash from Investing (Quarterly): 8.945M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.945M |
December 31, 2023 | 0.5978M |
September 30, 2023 | -0.5869M |
June 30, 2023 | -2.386M |
March 31, 2023 | -14.69M |
December 31, 2022 | -0.0019M |
September 30, 2022 | -0.1143M |
June 30, 2022 | 0.5944M |
March 31, 2022 | -4.188M |
December 31, 2021 | -7.129M |
September 30, 2021 | -1.271M |
June 30, 2021 | -0.2083M |
March 31, 2021 | -0.526M |
December 31, 2020 | -1.848M |
September 30, 2020 | 3.243M |
June 30, 2020 | 5.045M |
March 31, 2020 | 0.9854M |
December 31, 2019 | 0.2963M |
September 30, 2019 | -0.4772M |
June 30, 2019 | -3.875M |
March 31, 2019 | -7.965M |
December 31, 2018 | 0.0001M |
September 30, 2018 | -0.0107M |
June 30, 2018 | 0.00 |
March 31, 2018 | 1.566M |
Date | Value |
---|---|
December 31, 2017 | 5.067M |
September 30, 2017 | 4.070M |
June 30, 2017 | -3.937M |
March 31, 2017 | 5.158M |
December 31, 2016 | 4.716M |
September 30, 2016 | -0.2958M |
June 30, 2016 | 0.4518M |
March 31, 2016 | 6.548M |
December 31, 2015 | 0.01M |
September 30, 2015 | -10.22M |
June 30, 2015 | -13.38M |
March 31, 2015 | -0.0129M |
December 31, 2014 | 0.0005M |
September 30, 2014 | -0.0063M |
June 30, 2014 | -0.0196M |
March 31, 2014 | 0.00 |
December 31, 2013 | -0.0357M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.69M
Minimum
Mar 2023
8.945M
Maximum
Mar 2024
-0.8795M
Average
-0.3427M
Median
Cash from Investing (Quarterly) Benchmarks
BioXcel Therapeutics Inc | 0.00 |
ACADIA Pharmaceuticals Inc | -14.04M |
Cassava Sciences Inc | 0.00 |
Vertex Pharmaceuticals Inc | -2.136B |
Oragenics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -17.31M |
Cash from Financing (Quarterly) | -0.0971M |
Free Cash Flow | -45.70M |
Free Cash Flow Per Share (Quarterly) | -0.3021 |
Free Cash Flow Yield | -16.15% |